Professor Sarah Hilmer is nationally and internationally recognised for excellence in geriatric pharmacology. She has made significant, sustained contributions to the field since her PhD was awarded in 2005, with over 300 publications and 10,000 citations, and national and international collaborations. She has chaired institutional, state and international committees aiming to advance clinical pharmacology and therapeutics, particularly for older adults. She performs editorial responsibilities for gerontology and clinical pharmacology journals.

Professor Hilmer has built capacity in the emerging field of geriatric pharmacology through supervision of multidisciplinary higher degree students and mentorship of national and international early career clinician scientists. She actively engages with clinicians, policy makers and consumers to promote geriatric pharmacology research and practice.